Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Not Yet Recruiting

Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?

NCT04477876

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

NCT02498756

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer

NCT02718066

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations: [Site 02] Mayo Clinic Arizona Phoenix, Arizona, United States

[Site 11] University of California, San Diego Medical Center La Jolla, California, United States

[Site 01] Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States

[Site 09] H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, Florida, United States

View Trial Details

Completed

A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma

NCT00429312

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of California, Los Angeles Los Angeles, California, United States

Billings Clinic Billings, Montana, United States

Cancer Centers of the Carolinas Greenville, South Carolina, United States

View Trial Details

Completed

Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy

NCT06666634

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +23 more
Locations: NKI-AVL Amsterdam, Netherlands

View Trial Details

Completed

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

NCT02724488

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Melanoma, +11 more
Locations: Not specified

View Trial Details

Completed

Family Lifestyles, Actions, and Risk Education Intervention: Version 2

NCT04201223

Conditions: Child, Melanoma, Neoplasms, +10 more
Locations: Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +64 more
Locations: UCLA Medical Hematology & Oncology Los Angeles, California, United States

UCSF San Francisco, California, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists & Research Institute Sarasota, Florida, United States

View Trial Details

Completed

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

NCT04773951

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

Tumor Hospital affiliated to Harbin Medical University Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Nanjing Drum Tower Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

NCT06153238

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Sandoz Investigational Site Orange, California, United States

Sandoz Investigational Site Clermont, Florida, United States

Sandoz Investigational Site Orange City, Florida, United States

Sandoz Investigational Site Banja Luka, Bosnia and Herzegovina

View all 61 locations

View Trial Details